Status:
COMPLETED
Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University of Basel
University Hospital Freiburg
Conditions:
Neoplasm Metastasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this pilot study is to refine and test an advanced and adapted German version of the PRO-SELF© Plus Pain Control Program (PCP), an educational intervention directed at cancer pain patie...
Detailed Description
Background: Cancer patients experience multiple symptoms throughout the different stages of their illness, with pain as one of the most frequent. Even though effective treatment options exist, more th...
Eligibility Criteria
Inclusion
- Outpatients
- with cancer related pain ≥ 3 on a scale of 0-10 during the last two weeks,
- estimated life expectancy of \> 6 months as assessed by the physician,
- 18 years of age or older,
- able to understand, read and write German,
- have access to a telephone,
- live in a 1 hour distance around Freiburg or are willing to travel to Freiburg for each visit, agree to participate and give written in-formed consent
Exclusion
- documented previous or current psychiatric disorder or cognitive impairment as assessed by the physician (that is, unable to understand and provide informed consent),
- visual or hearing impairment that prevents adequate communication,
- a named FC who is not willing to participate in the study
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00920504
Start Date
June 1 2009
End Date
June 1 2011
Last Update
February 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tumorzentrum Ludwig Heilmeyer Comprehensive Cancer Center Freiburg
Freiburg im Breisgau, Germany, 79106